Drug Pipeline

Afatinib Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
6
Active Studies
4
Recruiting
5
Top Sponsors
Active Studies by Phase
Phase 2
4
Phase 1/2
1
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT05070403 Study of Afatinib in Advanced Cutaneous Squamous Cell Carcinoma Squamous Cell Carcinoma Recruiting
NCT07040956 A Clinical Trial Comparing Low-Dose RT + Targeted Therapy+ Immunotherapy vs Targeted… Head and Neck Squamous Cell Carcinoma Recruiting
NCT06385483 Testing Afatinib as Potentially Targeted Treatment in Cancers With EGFR Genetic Changes… Advanced Lymphoma Active, Not Recruiting
NCT02465060 Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced… Advanced Lymphoma Active, Not Recruiting
Phase 1/2
NCT06648096 Afatinib in Patients With Fanconi Anemia (FA) and Advanced Head and Neck Squamous Cell… Fanconi Anemia Recruiting
Phase 1
NCT06302621 Pemigatinib + Afatinib in Advanced Refractory Solid Tumors Advanced Solid Tumor Recruiting
Sponsors Running Afatinib Trials
National Cancer Institute (NCI) (2) H. Lee Moffitt Cancer Center and Research Institute (1) Massachusetts General Hospital (1) Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau (1) West China Hospital (1)
Disease Areas
Multiple Myeloma (2) Head & Neck Cancer (2) Lung Cancer (1) Breast Cancer (1) Prostate Cancer (1) Pancreatic Cancer (1) Gastric Cancer (1) Ovarian Cancer (1) Cervical Cancer (1) Endometrial Cancer (1)
Get alerts when Afatinib trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free